Clinical trial · Observational
Reliability and Validity of Mediterranean Colorectal Cancer Registry
NCT03864640CI-TRIAL-00042815completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The study will examine the validity and reliability of the Mediterranean Colorectal Cancer Registry. Aspects of the analysis will cover parallel forms reliability, test-retest reliability, split half internal consistency and face validity of the Mediterranean Colorectal Cancer Registry.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Registries | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (1)
- label
- Colorectal cancer
- description
- Patients with colorectal cancer
Primary outcomes (2)
- measure
- Construct validity of Mediterranean Colorectal Cancer Registry: answering multiple-choice items
- timeFrame
- 2 week
- description
- Construct validity will be based on the combination of qualitative and statistical methods in order to develop representative and structured set of multiple-choice items for colorectal cancer registry.
- measure
- Content validity of Mediterranean Colorectal Cancer Registry: answering multiple-choice items
- timeFrame
- 2 week
- description
- Content validity will be based on the combination of qualitative and statistical methods in order to develop shortest-possible but well-matched set of multiple-choice items reflecting the subjects being assessed in the colorectal cancer registry. .
Secondary outcomes (5)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Adult patients with colorectal cancer. Exclusion Criteria: * Patients reluctant to participate in the study.
References
Publications (0)
Data not yet available
No reference posted for this study.